State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Pancreas (Late Stage^), 2018-2022

All Races (includes Hispanic), Female, All Ages

Sorted by Rate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.6 to 8.7 and 19,583 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Puerto Rico²

• Rate : The incidence rate is 4.2 with a 95% confidence interval from 3.9 to 4.6 and 119 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 6.1 to 7.1 and 131 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (45, 51)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 6.7 with a 95% confidence interval from 6.1 to 7.3 and 103 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (42, 51)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 7.1 with a 95% confidence interval from 6.7 to 7.5 and 257 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (41, 51)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 6.7 to 8.0 and 112 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (31, 51)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 7.4 with a 95% confidence interval from 7.1 to 7.7 and 376 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (37, 50)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 7.5 with a 95% confidence interval from 7.1 to 8.0 and 263 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (33, 50)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.1 to 8.1 and 195 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (31, 50)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.1 to 8.2 and 160 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (28, 50)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.4 to 8.1 and 362 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (32, 48)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.4 to 8.1 and 451 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (31, 48)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.1 to 8.5 and 99 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (20, 50)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.3 to 8.5 and 152 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (24, 49)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 6.6 to 9.3 and 30 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (4, 51)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.2 to 8.7 and 91 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (16, 50)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.6 to 8.5 and 242 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (23, 47)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 6.8 to 9.5 and 30 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (3, 51)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 8.2 with a 95% confidence interval from 8.0 to 8.4 and 1,323 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (27, 40)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.3 to 9.2 and 64 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (6, 50)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 7.5 to 9.1 and 86 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (8, 49)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 7.9 to 8.7 and 316 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (18, 42)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 8.2 to 8.5 and 2,032 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (25, 38)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 7.6 to 9.2 and 91 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (7, 48)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 7.6 to 9.5 and 68 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (3, 49)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.3 to 8.7 and 1,506 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (20, 35)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 7.9 to 9.4 and 102 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (5, 45)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.2 to 9.1 and 327 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (14, 39)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.4 to 9.0 and 734 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (16, 34)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.3 to 9.1 and 368 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (12, 37)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.2 to 9.4 and 180 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (5, 39)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.5 to 9.3 and 385 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (9, 33)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 7.7 to 10.2 and 44 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (1, 49)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.5 to 9.3 and 446 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (9, 33)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 9.0 with a 95% confidence interval from 7.8 to 10.4 and 42 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (1, 48)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.6 to 9.4 and 412 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (7, 30)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.0 to 10.3 and 53 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (1, 46)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.7 to 9.5 and 379 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (5, 30)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.7 to 9.7 and 284 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (3, 30)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.9 to 9.5 and 666 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (5, 25)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 9.3 with a 95% confidence interval from 8.6 to 10.1 and 127 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (1, 36)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 9.1 to 9.7 and 681 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (3, 21)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.8 to 10.0 and 211 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (2, 29)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.5 to 10.5 and 73 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (1, 38)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 9.1 to 9.8 and 633 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (2, 21)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 9.1 to 9.9 and 468 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (2, 22)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 9.2 to 9.8 and 825 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (3, 19)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.3 to 9.8 and 947 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (3, 18)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.4 to 9.8 and 1,387 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (3, 16)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 9.9 with a 95% confidence interval from 9.6 to 10.3 and 649 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 14)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 10.0 with a 95% confidence interval from 9.5 to 10.6 and 268 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 17)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 10.4 with a 95% confidence interval from 9.9 to 11.0 and 321 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 7)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 10.8 with a 95% confidence interval from 9.3 to 12.4 and 40 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 29)
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/13/2026 9:38 pm.

State Cancer Registries may provide more current or more local data.



† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

² Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

⁷ Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.